Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Ophthalmology

The Genetics & Biology of Stargardt Disease

At a Glance

Stargardt disease is primarily caused by mutations in the ABCA4 gene, which breaks the eye's ability to recycle Vitamin A. This leads to a toxic buildup of lipofuscin that damages vision cells. Genetic testing can confirm your exact mutation and help explain risks to your family members.

Understanding the biological machinery of your eyes can help demystify why vision changes are occurring. Stargardt disease is not caused by a single event, but rather by a specific breakdown in the “recycling system” of your photoreceptors—the light-sensing cells in the back of your eye [1][2].

The ABCA4 “Flippase” Protein

Think of your photoreceptor cells as tiny factories that process light. Every time these cells detect light, they use a form of Vitamin A. After the light is processed, the used Vitamin A needs to be moved out of the cell’s delicate machinery to be recycled [3].

In more than 80% of Stargardt cases (STGD1), the problem lies in the ABCA4 gene [4]. This gene provides instructions for a protein called a flippase [5]. True to its name, this protein “flips” used Vitamin A molecules across a membrane so they can be safely removed and recycled [6][3].

The Build-up of Toxic Waste

When the ABCA4 flippase is broken or missing, the used Vitamin A gets stuck. It begins to clump together, forming toxic molecules known as bisretinoids, the most common of which is called A2E [1][7].

  1. Toxic Clumping: These A2E molecules cannot be broken down by the eye [1].
  2. Lipofuscin Accumulation: As the photoreceptors shed their waste, these toxins are swallowed by a support layer called the Retinal Pigment Epithelium (RPE). The waste builds up as a yellowish pigment called lipofuscin [2][7].
  3. Cell Death: Over time, this “trash” becomes so toxic that it kills the RPE cells. Because the photoreceptors depend on the RPE for survival, they eventually die as well, leading to central vision loss [8][6].

One Disease, Different Genes

While most people with Stargardt have the STGD1 type (autosomal recessive), other rarer forms exist that are inherited differently:

Type Gene Inheritance Mechanism
STGD1 ABCA4 Autosomal Recessive Broken “flippase” recycling protein [4][9]
STGD3 ELOVL4 Autosomal Dominant Problem making essential fatty acids for the retina [10][11]
STGD4 PROM1 Autosomal Dominant Structural issues in the photoreceptor cells [12]

Note: Autosomal recessive means you must inherit a broken gene from both parents. Autosomal dominant means you only need one broken gene from one parent to have the condition.

Sometimes, other conditions like PRPH2-associated dystrophies can look exactly like Stargardt disease under a microscope. These are called phenocopies [13][14]. This is why genetic testing is so important—it identifies the exact “broken part” to ensure the diagnosis is correct.

Reading Your Genetic Report: Null vs. Mild

When you receive a genetic report for ABCA4, you will see the specific mutations listed. Doctors often categorize these based on how much “work” the flippase protein can still do:

  • Null Mutations: These are severe “stop” signs. They tell the cell to stop making the protein entirely. If a person has two null mutations, they typically experience an earlier onset and more rapid vision loss [15][16].
  • Mild (Hypomorphic) Mutations: These are like a “glitch.” The protein is made, but it works slowly or inefficiently. If a person has at least one mild mutation, the disease often starts later in life and progresses more slowly because some recycling is still happening [15][17].

To have STGD1, a person usually needs two mutations. If your report shows two mutations, your doctor may suggest testing your parents (segregation testing) to confirm they are “in trans”—meaning one mutation came from each parent [18][19]. If your report only shows one mutation, segregation testing cannot determine if it’s the only one. In that case, advanced testing, such as deep intronic sequencing, may be required to find the missing second mutation.

Family Planning & Genetic Counseling

Because Stargardt disease is genetic, it is entirely normal to wonder about the risks to your siblings or future children.

  • Siblings: If you have the recessive form (STGD1), your full siblings have a 25% chance of also inheriting the condition from your parents.
  • Children: If you have STGD1, you will pass one mutated gene to your children. However, unless your partner is also a carrier for an ABCA4 mutation (which is relatively rare in the general population), your children will be carriers but will not develop the disease.

It is highly recommended to consult with a Genetic Counselor. They are specially trained to review your family history, explain your specific inheritance risks, and guide you through testing options for your family [20].

Common questions in this guide

What does the ABCA4 gene do in the eye?
The ABCA4 gene provides instructions for a protein called a flippase. This protein helps recycle Vitamin A after your eye processes light, preventing toxic waste from building up in your vision cells.
What is lipofuscin and how does it affect vision?
Lipofuscin is a yellowish, toxic waste pigment that builds up when the eye cannot properly recycle used Vitamin A. Over time, this buildup destroys the support cells and light-sensing cells in your retina, leading to central vision loss.
What is the difference between null and mild ABCA4 mutations?
Null mutations stop the cell from making the recycling protein entirely, which often leads to earlier and faster vision loss. Mild mutations allow the protein to work slowly, usually resulting in disease that starts later and progresses more gradually.
Why is genetic testing important for Stargardt disease?
Genetic testing identifies the exact gene mutation causing your vision loss, which confirms your diagnosis and helps predict disease progression. It also clarifies how the condition is inherited so you can understand the risks for your siblings and future children.
Will I pass Stargardt disease to my children?
If you have the most common recessive form of Stargardt disease, you will pass one mutated gene to your children. However, unless your partner is also a carrier of an ABCA4 mutation, your children will only be carriers and will not develop the disease.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many pathogenic variants were identified in my genetic report, and are they 'null' or 'mild' mutations?
  2. 2.Was segregation testing performed (testing parents) to confirm that the two mutations are on different chromosomes?
  3. 3.Does my genetic report suggest STGD1, or is there evidence of an autosomal dominant form like STGD3 or STGD4?
  4. 4.How does the specific combination of mutations found in my report typically relate to the age of onset and the speed of vision changes?
  5. 5.If only one mutation or a 'Variant of Uncertain Significance' (VUS) was found, what are the next steps for clarifying the diagnosis?
  6. 6.Can you refer us to a genetic counselor to discuss the risks for siblings and future children?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Dual ABCA4-AAV Vector Treatment Reduces Pathogenic Retinal A2E Accumulation in a Mouse Model of Autosomal Recessive Stargardt Disease.

    Dyka FM, Molday LL, Chiodo VA, et al.

    Human gene therapy 2019; (30(11)):1361-1370 doi:10.1089/hum.2019.132.

    PMID: 31418294
  2. 2

    Insights into the Molecular Properties of ABCA4 and Its Role in the Visual Cycle and Stargardt Disease.

    Molday RS

    Progress in molecular biology and translational science 2015; (134()):415-31.

    PMID: 26310168
  3. 3

    Localization and functional characterization of the p.Asn965Ser (N965S) ABCA4 variant in mice reveal pathogenic mechanisms underlying Stargardt macular degeneration.

    Molday LL, Wahl D, Sarunic MV, Molday RS

    Human molecular genetics 2018; (27(2)):295-306 doi:10.1093/hmg/ddx400.

    PMID: 29145636
  4. 4

    Stargardt Disease: Gene Therapy Strategies for ABCA4.

    Ku CA, Yang P

    International ophthalmology clinics 2021; (61(4)):157-165 doi:10.1097/IIO.0000000000000375.

    PMID: 34584053
  5. 5

    Expression of ABCA4 in the retinal pigment epithelium and its implications for Stargardt macular degeneration.

    Lenis TL, Hu J, Ng SY, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2018; (115(47)):E11120-E11127 doi:10.1073/pnas.1802519115.

    PMID: 30397118
  6. 6

    Membrane Attack Complex Mediates Retinal Pigment Epithelium Cell Death in Stargardt Macular Degeneration.

    Ng ESY, Kady N, Hu J, et al.

    Cells 2022; (11(21)) doi:10.3390/cells11213462.

    PMID: 36359858
  7. 7

    More insights from Abca4-/- mouse models of recessive Stargardt disease.

    Zhao J, Montenegro D, Cheng S, et al.

    The Journal of biological chemistry 2026; (302(3)):111261 doi:10.1016/j.jbc.2026.111261.

    PMID: 41654128
  8. 8

    Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4-/-/Bco2-/- double knockout mice.

    Arunkumar R, Gorusupudi A, Li B, et al.

    Experimental eye research 2021; (209()):108680 doi:10.1016/j.exer.2021.108680.

    PMID: 34161819
  9. 9

    Proposing Zebrafish as a Model for Stargardt Disease.

    Lu Q, Reynolds AL

    Advances in experimental medicine and biology 2025; (1468()):219-223 doi:10.1007/978-3-031-76550-6_36.

    PMID: 39930199
  10. 10

    Long-term follow-up of autosomal dominant Stargardt macular dystrophy (STGD3) subjects enrolled in a fish oil supplement interventional trial.

    Choi R, Gorusupudi A, Bernstein PS

    Ophthalmic genetics 2018; (39(3)):307-313 doi:10.1080/13816810.2018.1430240.

    PMID: 29377748
  11. 11

    Stargardt Phenotype Associated With Two ELOVL4 Promoter Variants and ELOVL4 Downregulation: New Possible Perspective to Etiopathogenesis?

    Donato L, Scimone C, Rinaldi C, et al.

    Investigative ophthalmology & visual science 2018; (59(2)):843-857 doi:10.1167/iovs.17-22962.

    PMID: 29417145
  12. 12

    MACULAR ATROPHY AND PHENOTYPIC VARIABILITY IN AUTOSOMAL DOMINANT STARGARDT-LIKE MACULAR DYSTROPHY DUE TO PROM1 MUTATION.

    Ricca AM, Han IC, Hoffmann J, et al.

    Retina (Philadelphia, Pa.) 2023; (43(7)):1165-1173 doi:10.1097/IAE.0000000000003784.

    PMID: 36930890
  13. 13

    Commentary on "Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes".

    Dhooge PPA, Mulders TWF, Hoyng CCB

    Redox biology 2021; (45()):101957 doi:10.1016/j.redox.2021.101957.

    PMID: 33849814
  14. 14

    A Family Affected by Novel C213W Mutation in PRPH2: Long-Term Follow-Up of CNV Secondary to Pattern Dystrophy.

    Lee CS, Leys M

    Ophthalmic surgery, lasers & imaging retina 2020; (51(6)):354-362 doi:10.3928/23258160-20200603-06.

    PMID: 32579694
  15. 15

    Genetic and Clinical Features of ABCA4-Associated Retinopathy in a Japanese Nationwide Cohort.

    Mizobuchi K, Hayashi T, Tanaka K, et al.

    American journal of ophthalmology 2024; (264()):36-43 doi:10.1016/j.ajo.2024.03.007.

    PMID: 38499139
  16. 16

    Targeted next-generation sequencing identifies ABCA4 mutations in Chinese families with childhood-onset and adult-onset Stargardt disease.

    Qu LH, Jin X, Zeng C, et al.

    Bioscience reports 2021; (41(6)) doi:10.1042/BSR20203497.

    PMID: 33988224
  17. 17

    Expanding the Mutation Spectrum in ABCA4: Sixty Novel Disease Causing Variants and Their Associated Phenotype in a Large French Stargardt Cohort.

    Nassisi M, Mohand-Saïd S, Dhaenens CM, et al.

    International journal of molecular sciences 2018; (19(8)) doi:10.3390/ijms19082196.

    PMID: 30060493
  18. 18

    Novel Variants in ABCA4-Related Retinopathies with Structural Re-Assessment of Variants of Uncertain Significance.

    Gregory-Evans K, Kolawole OU, Molday RS, Gregory-Evans CY

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2024; (247(4)):231-240 doi:10.1159/000540361.

    PMID: 39043154
  19. 19

    Association of Sex With Frequent and Mild ABCA4 Alleles in Stargardt Disease.

    Runhart EH, Khan M, Cornelis SS, et al.

    JAMA ophthalmology 2020; (138(10)):1035-1042 doi:10.1001/jamaophthalmol.2020.2990.

    PMID: 32815999
  20. 20

    Multimodal imaging in autosomal recessive Stargardt's disease.

    Agarwal S, Nayak MA, Sood S

    BMJ case reports 2025; (18(5)) doi:10.1136/bcr-2023-257508.

    PMID: 40355273

This page explains the genetics and biology of Stargardt disease for educational purposes only. Always consult a genetic counselor or ophthalmologist to interpret your specific genetic testing report and inheritance risks.

Get notified when new evidence is published on Stargardt disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.